Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerus Corp (CERS)  
$1.78 0.11 (5.82%) as of 4:30 Fri 6/7


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 167,140,000
Market Cap: 297.51(M)
Last Volume: 551,809 Avg Vol: 1,588,801
52 Week Range: $1.25 - $3.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    : 7.6
Insider 6 Months    : 8.6
Insider 3/6 Months : 16
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerus is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The INTERCEPT Blood System, which is based on Co.'s technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Co.'s INTERCEPT Blood System is intented for use with blood components including platelets, plasma and red blood cells. Co. has received U.S. Food and Drug Administration approval for the INTERCEPT Blood System for Cryoprecipitation, which uses Co.'s plasma system to produce INTERCEPT Fibrinogen Complex for the treatment and control of bleeding.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 27,000 37,000 54,500 74,350
Total Buy Value $51,042 $67,242 $97,031 $136,547
Total People Bought 4 5 6 7
Total Buy Transactions 4 5 7 10
Total Shares Sold 340,967 370,345 370,345 575,085
Total Sell Value $688,865 $759,322 $759,322 $1,393,255
Total People Sold 7 7 7 8
Total Sell Transactions 13 14 14 24
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 548
  Page 18 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Anderson Timothy B Director   –       •      –    2013-11-19 4 OE $2.95 $9,835 D/D 3,334 52,732     -
   Corash Laurence M Chief Med & Scientific Officer   •       •      –    2013-11-12 4 OE $4.25 $4,250 D/D 1,000 571,756     -
   Cozadd Bruce C Director   –       •      –    2013-11-11 4 OE $4.54 $15,136 D/D 3,334 3,334     -
   Corash Laurence M Chief Med & Scientific Officer   •       •      –    2013-11-08 4 OE $4.25 $144,500 D/D 34,000 605,756     -
   Cassin Bj Director   –       •      –    2013-11-04 4 D $6.31 $31,550 D/D (5,000) 0     -
   Cassin Bj Director   –       •      –    2013-11-04 4 OE $4.54 $22,700 D/D 5,000 5,000     -
   Anderson Timothy B Director   –       •      –    2013-11-01 4 OE $4.54 $9,493 D/D 2,091 49,398     -
   Greenman William Mariner President and CEO   •       •      –    2013-08-22 4 OE $4.25 $73,313 D/D 17,250 143,065     -
   Hogeboom Caspar Jan President, Cerus Europe   •       –      –    2013-08-05 4 D $5.90 $28,509 D/D (4,832) 0     -
   Hogeboom Caspar Jan President, Cerus Europe   •       –      –    2013-08-02 4 D $5.85 $14,134 D/D (2,416) 4,832     -
   Moore Carol SR. V.P. Regulatory, ClinicalO   •       –      –    2013-04-18 3 IO $0.00 $0 D/D 0 3,074     -
   Green Kevin Dennis Chief Accounting Officer   •       –      –    2013-01-07 4 D $2.95 $4,171 D/D (1,414) 17,202     -
   Corash Laurence M Chief Medical Officer   •       •      –    2013-01-07 4 D $2.95 $10,160 D/D (3,444) 570,756     -
   Ervin Howard G Vice President, Legal Affairs   •       –      –    2013-01-07 4 D $2.95 $8,437 D/D (2,860) 42,846     -
   Greenman William Mariner President & CEO   •       •      –    2013-01-07 4 D $2.95 $8,455 D/D (2,866) 125,815     -
   Anderson Timothy B Director   –       •      –    2012-11-27 4 OE $0.79 $34,519 D/D 43,125 43,125     -
   Greenman William Mariner President and CEO   •       •      –    2012-11-19 4 B $3.02 $9,664 D/D 3,200 128,681 2.81     -
   Greenman William Mariner President and CEO   •       •      –    2012-11-16 4 B $2.82 $39,387 D/D 13,800 125,481 2.81     -
   Corash Laurence M Chief Medical Officer   •       •      –    2012-11-16 4 B $2.85 $5,698 D/D 2,000 574,200 2.81     -
   Cassin Bj Director   –       •      –    2012-09-13 4 GD $0.00 $0 I/I 320,000 77,384     -
   Greenman William Mariner President and CEO   •       •      –    2012-02-29 4 A $1.77 $21,251 D/D 12,020 111,681     -
   Corash Laurence M Chief Medical Officer   •       •      –    2011-11-14 4 B $2.80 $46,472 D/D 16,597 572,200 2.81     -
   Corash Laurence M Chief Medical Officer   •       •      –    2011-11-11 4 B $2.83 $94,530 D/D 33,403 555,603 2.81     -
   Corash Laurence M Chief Medical Officer   •       •      –    2011-05-19 4 B $2.95 $35,458 D/D 12,000 522,200 2.81     -
   Corash Laurence M Chief Medical Officer   •       •      –    2011-05-18 4 B $2.92 $10,210 D/D 3,500 510,200 2.81     -
  548 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 18 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us